138 related articles for article (PubMed ID: 9701723)
1. Cathepsin D: association between TN-stage and steroid receptor status of breast carcinoma.
Nikolić-Vukosavljević D; Grujić-Adanja G; Nastić-Mirić D; Branković-Magić M; Jovanović D; Polić D; Mitrović L
Tumour Biol; 1998; 19(5):329-34. PubMed ID: 9701723
[TBL] [Abstract][Full Text] [Related]
2. Estrogen-regulated cut-off values of pS2 and cathepsin D expression in breast carcinomas.
Markićević M; Petrović A; Kanjer K; Nesković-Konstantinović Z; Nikolić-Vukosavujević D
Adv Exp Med Biol; 2008; 617():341-8. PubMed ID: 18497057
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of cathepsin D as prognostic predictor in breast cancer.
Barbi GP; Margallo E; Margiocco M; Paganuzzi M; Marroni P; Costanzi B; Gatteschi B; Tanara G; Spina B; Nicolò G
Oncology; 1994; 51(4):329-33. PubMed ID: 8208515
[TBL] [Abstract][Full Text] [Related]
4. Relationship between cathepsin D and other pathological and biological parameters in 1752 patients with primary breast cancer.
Gion M; Mione R; Dittadi R; Romanelli M; Pappagallo L; Capitanio G; Friede U; Barbazza R; Visonà A; Dante S
Eur J Cancer; 1995; 31A(5):671-7. PubMed ID: 7640037
[TBL] [Abstract][Full Text] [Related]
5. Cathepsin B, a prognostic indicator in lymph node-negative breast carcinoma patients: comparison with cathepsin D, cathepsin L, and other clinical indicators.
Lah TT; Cercek M; Blejec A; Kos J; Gorodetsky E; Somers R; Daskal I
Clin Cancer Res; 2000 Feb; 6(2):578-84. PubMed ID: 10690542
[TBL] [Abstract][Full Text] [Related]
6. Significance of the tumor protease cathepsin D for the biology of breast cancer.
Dian D; Heublein S; Wiest I; Barthell L; Friese K; Jeschke U
Histol Histopathol; 2014 Apr; 29(4):433-8. PubMed ID: 24265119
[TBL] [Abstract][Full Text] [Related]
7. [Cathepsin D in primary breast cancer in correlation with various prognostic factors].
Rempen A; Caffier H
Geburtshilfe Frauenheilkd; 1991 Apr; 51(4):272-5. PubMed ID: 1650323
[TBL] [Abstract][Full Text] [Related]
8. [The prognostic value of cathepsin D concentration in cytosol of primary breast carcinoma].
Bussen S; Rempen A; Caffier H
Zentralbl Gynakol; 1995; 117(5):253-9. PubMed ID: 7793167
[TBL] [Abstract][Full Text] [Related]
9. [Cathepsin D expression in primary breast cancer. Comparison of immunohistochemical and biochemical results].
Göhring UJ; Ingenhorst A; Crombach G; Scharl A
Pathologe; 1993 Dec; 14(6):313-7. PubMed ID: 8121884
[TBL] [Abstract][Full Text] [Related]
10. Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer.
Thorpe SM; Rochefort H; Garcia M; Freiss G; Christensen IJ; Khalaf S; Paolucci F; Pau B; Rasmussen BB; Rose C
Cancer Res; 1989 Nov; 49(21):6008-14. PubMed ID: 2790815
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of PS2 and cathepsin D in 710 human primary breast tumors: multivariate analysis.
Foekens JA; van Putten WL; Portengen H; de Koning HY; Thirion B; Alexieva-Figusch J; Klijn JG
J Clin Oncol; 1993 May; 11(5):899-908. PubMed ID: 8487052
[TBL] [Abstract][Full Text] [Related]
12. Cathepsin D-related disease-free interval in pT1 primary breast carcinomas: a pilot study.
Nikolić-Vukosavljević D; Markićević M; Grujić-Adanja G; Petrović A; Kanjer K; Nesković-Konstantinović Z
Clin Exp Metastasis; 2005; 22(4):363-8. PubMed ID: 16170672
[TBL] [Abstract][Full Text] [Related]
13. Cathepsin D as a prognostic indicator for node-negative breast cancer patients using both immunoassays and enzymatic assays.
Kute TE; Shao ZM; Sugg NK; Long RT; Russell GB; Case LD
Cancer Res; 1992 Oct; 52(19):5198-203. PubMed ID: 1394123
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of cathepsin D assay in breast cancer tissues.
Itoh Y; Kobayashi S; Iwase H; Yamashita H; Kuzushima T; Iwata H; Yamashita T; Naitoh A; Itoh K; Masaoka A
J Surg Oncol; 1995 Dec; 60(4):221-6. PubMed ID: 8551729
[TBL] [Abstract][Full Text] [Related]
15. Cathepsin D levels in primary breast cancers: relationship with epidermal growth factor receptor, oestrogen receptor and axillary nodal status.
Sacks NP; Smith K; Norman AP; Greenall M; LeJeune S; Harris AL
Eur J Cancer; 1993; 29A(3):426-8. PubMed ID: 8398346
[TBL] [Abstract][Full Text] [Related]
16. Relation between cathepsin D expression and other prognostic factors in breast carcinomas.
Shaheen RM; Miseljic S; Wiehle RD; Wittliff JL
Clin Chem; 1995 Nov; 41(11):1585-91. PubMed ID: 7586547
[TBL] [Abstract][Full Text] [Related]
17. [Expression of cathepsin D in breast cancer and its clinical and histopathological correlations].
Ramírez-Ortega MC; Frías-Mendívil M; Delgado-Chávez R; Meneses-García A; Carrillo-Hernández JF; Ramírez-Ugalde MT; Zeichner-Gancz I
Rev Invest Clin; 1997; 49(5):361-8. PubMed ID: 9527695
[TBL] [Abstract][Full Text] [Related]
18. Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer.
Isola J; Weitz S; Visakorpi T; Holli K; Shea R; Khabbaz N; Kallioniemi OP
J Clin Oncol; 1993 Jan; 11(1):36-43. PubMed ID: 8093367
[TBL] [Abstract][Full Text] [Related]
19. Impact of steroid receptors, pS2 and cathepsin D on the outcome of N+ postmenopausal breast cancer patients treated with tamoxifen.
Dittadi R; Biganzoli E; Boracchi P; Salbe C; Mione R; Gatti C; Gion M
Int J Biol Markers; 1998; 13(1):30-41. PubMed ID: 9681297
[TBL] [Abstract][Full Text] [Related]
20. Cathepsin D in host stromal cells, but not in tumor cells, is associated with aggressive behavior in node-negative breast cancer.
Nadji M; Fresno M; Nassiri M; Conner G; Herrero A; Morales AR
Hum Pathol; 1996 Sep; 27(9):890-5. PubMed ID: 8816882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
